At Oxurion, our mission is to pioneer life-changing treatments that prevent blindness and enhance vision for patients worldwide. Specializing in retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD) we are committed to addressing unmet medical needs in ophthalmology.
02. Our Committement
Our vision is your vision, and we are united by the shared goal of helping people see better. Through our commitment, we strive to transform lives, helping people see better, and bring hope and enhanced quality of life to millions.
Oxurion is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Our ambition is to build an integrated group of subcontractors serving healthcare stakeholders. Oxurion holds a 72% stake in Axiodis CRO, a subcontractor specialized in biometrics.